Quest Diagnostics, Inc [DGX] stock prices are down -2.73% to $151.25 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DGX shares have lost -2.85% over the last week, with a monthly amount drifted -6.70%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on December 17, 2024, when Morgan Stanley upgraded its rating to a Overweight and also boosted its price target to $172 from $145. On October 23, 2024, upgrade upgraded it’s rating to Outperform and revised its price target to $182 on the stock. Citigroup upgraded its rating to a Buy and raised its price target to $165 on July 10, 2024. Leerink Partners started tracking with a Market Perform rating for this stock on February 26, 2024, and assigned it a price target of $135. In a note dated February 07, 2024, Jefferies upgraded an Buy rating on this stock and boosted its target price from $140 to $155.
The stock price of Quest Diagnostics, Inc [DGX] has been fluctuating between $123.04 and $165.32 over the past year. Currently, Wall Street analysts expect the stock to reach $171.86 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $151.25 at the most recent close of the market. An investor can expect a potential return of 13.63% based on the average DGX price forecast.
Analyzing the DGX fundamentals
The Quest Diagnostics, Inc [NYSE:DGX] reported sales of 9.54B for trailing twelve months, representing a surge of 8.41%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 149.65 points at the first support level, and at 148.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 154.44, and for the 2nd resistance point, it is at 157.64.
Ratios To Look Out For
It’s worth pointing out that Quest Diagnostics, Inc [NYSE:DGX]’s Current Ratio is 1.25. In addition, the Quick Ratio stands at 1.17 and the Cash Ratio stands at 0.37. Considering the valuation of this stock, the price to sales ratio is 1.77, the price to book ratio is 2.49 and price to earnings (TTM) ratio is 20.30.
Transactions by insiders
Recent insider trading involved PREVOZNIK MICHAEL E, SVP & General Counsel, that happened on Nov 29 ’24 when 35146.0 shares were sold. EVP, Regional Businesses, Doherty Catherine T. completed a deal on Nov 27 ’24 to sell 33103.0 shares. Meanwhile, Officer PREVOZNIK MICHAEL E bought 35146.0 shares on Nov 29 ’24.
